🔬 Science

Koalas Lost Almost All Their Genetic Diversity. Now Science Shows They're Getting It Back.

Koalas Lost Almost All Their Genetic Diversity. Now Science Shows They're Getting It Back.

Conservation science has long held a painful truth: when a species passes through a severe population bottleneck — reduced to just a handful of individuals — the genetic damage is effectively permanent. The diversity that took millions of years to accumulate simply cannot be recovered in human timescales.

A landmark study published in **Science** in March 2026 is challenging that assumption, and the species doing the challenging is one of Australia's most beloved: the koala.

**The Study**

Researchers from the **University of Sydney** and collaborating institutions analysed whole-genome data from **418 koalas** across **27 Australian populations** — the most comprehensive genomic survey of the species ever conducted. What they found overturned decades of conservation assumptions.

Victorian koalas once faced one of the most extreme genetic bottlenecks ever documented in a mammal. The entire Victorian population was reduced to as few as **102 individuals** — an almost incomprehensibly small genetic reservoir — before recovering to around 494 individuals over approximately 35 generations.

Conventional genetics predicted permanent damage: reduced heterozygosity, accumulated harmful mutations, and an evolutionary ceiling that would leave the population permanently vulnerable.

Instead, the genomes tell a different story.

**What the Genomes Revealed**

The researchers found that as the population grew rapidly after the bottleneck, two natural forces went to work:

🔀 **Recombination** — the natural reshuffling of genetic material during reproduction, which generates new combinations of existing genetic variants. A larger, growing population has more opportunities for these reshufflings, effectively creating new genetic variation from old building blocks.

🧬 **New mutations** — larger populations also accumulate more new mutations over time, each one introducing novel genetic variation that can gradually rebuild diversity.

Together, these processes are measurably reversing the genetic damage of the bottleneck. The Victorian koalas are not only recovering in numbers — they are recovering in **evolutionary potential**.

**Why This Changes Conservation Science**

The findings have profound implications for how we think about endangered species recovery. Currently, conservation assessments heavily weight genetic diversity as a static measurement: how much diversity does a population have right now? Species with low genetic diversity are often classified as more endangered, more fragile, more vulnerable to disease and climate shifts.

This study suggests those assessments may be missing a crucial variable: **trajectory**.

"Rather than focusing solely on static measures of genetic diversity, conservation strategies should consider whether populations are expanding, stabilising, or declining," the researchers conclude. A population that has low diversity but is growing rapidly may be on a path to genuine recovery — not a slow death.

For species managers working with populations of mountain gorillas, northern white rhinos, the California condor, or dozens of other species that have passed through devastating bottlenecks, this is transformative news.

**The Koala Context**

Koalas are listed as **Endangered** in Australia, having lost significant habitat to bushfires, land clearing, and disease (particularly chlamydia). The 2019–2020 Black Summer bushfires killed or displaced an estimated **60,000 koalas** and destroyed vast stretches of their habitat.

Yet the Victorian population — precisely because it is descended from that tiny founding group — has been rebuilding. And now genomic science confirms that the rebuilding goes deeper than anyone previously expected.

This isn't just a story about koalas. It's a message about what's possible when we give nature the space and time to recover. Genetics, it turns out, can surprise us. 🐨

*Sources: University of Sydney (March 2026) · Science journal · ScienceDaily · Smithsonian Magazine · ScienceNews*

🌅 Get Good News in Your Inbox

Join thousands who start their day with uplifting stories. Free, no spam, unsubscribe anytime.

More Science Stories

A Single Graduate Student Just Mapped 7 Million Cells Across 21 Organs — and It Changes What We Know About Aging

A Single Graduate Student Just Mapped 7 Million Cells Across 21 Organs — and It Changes What We Know About Aging

Researchers at The Rockefeller University have built the most comprehensive cellular atlas of aging ever created — nearl…

Scientists Discover That Parts of Greenland's Ice Sheet 'Boil Like Pasta' — and It Could Improve Sea Level Predictions

Scientists Discover That Parts of Greenland's Ice Sheet 'Boil Like Pasta' — and It Could Improve Sea Level Predictions

Mysterious plume-like structures deep inside the Greenland ice sheet have puzzled scientists for over a decade. Now a te…

Scientists Just Found That Two Gut Bacteria Can Make Their Own Serotonin — and It Could Change How We Treat IBS

Scientists Just Found That Two Gut Bacteria Can Make Their Own Serotonin — and It Could Change How We Treat IBS

In a discovery that reshapes understanding of the gut-brain axis, researchers have identified two specific gut bacteria …

✨ You Might Also Like

From 30,000 Birds to 6 Million: How America Brought the Wild Turkey Back From the Brink

From 30,000 Birds to 6 Million: How America Brought the Wild Turkey Back From the Brink

By the 1930s, wild turkeys had been hunted and habitat-stripped to as few as 30,000 birds — absent from 18 states, headi…

The 'Nobel Prize of the Environment' Just Went to the Scientist Who Proved Fungi Are Quietly Saving the Planet

The 'Nobel Prize of the Environment' Just Went to the Scientist Who Proved Fungi Are Quietly Saving the Planet

Evolutionary biologist Toby Kiers has been awarded the 2026 Tyler Prize for Environmental Achievement — the world's most…

The World's First Personalised mRNA Cancer Vaccine Is Showing 5-Year Results — and the Phase 3 Trial Is Enrolling Now

The World's First Personalised mRNA Cancer Vaccine Is Showing 5-Year Results — and the Phase 3 Trial Is Enrolling Now

The world's first personalised mRNA cancer vaccine — mRNA-4157/V940, developed by Moderna and Merck — has now produced f…